|
2023
|
Invention
|
Methods of administering immunosuppressants having a specified pharmacodynamic effective life and... |
|
|
Invention
|
Compositions and methods for treating primary biliary cholangitis. Provided herein are methods an... |
|
|
Invention
|
Tolerogenic synthetic nanocarriers for allergy therapy.
Disclosed are synthetic nanocarrier comp... |
|
|
Invention
|
Compositions and methods related to immunoglobulin proteases and fusions thereof. Provided herein... |
|
|
Invention
|
Viral vector dosing protocols.
Disclosed, at least in part, are dosings of viral vectors concomi... |
|
|
Invention
|
Tolerogenic synthetic nanocarriers.
This invention relates, at least in part, to compositions co... |
|
|
Invention
|
High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance.
Disclos... |
|
|
Invention
|
High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance. Disclose... |
|
|
Invention
|
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 rec... |
|
|
Invention
|
Methods and compositions for attenuating anti-viral transfer vector immune responses.
Provided h... |
|
|
Invention
|
Immunosuppressants in combination with anti-igm agents and related dosing.
Provided herein are m... |
|
|
Invention
|
Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosing.
D... |
|
|
Invention
|
Immunosuppressants in combination with anti-igm agents and related dosing. Provided herein are me... |
|
|
Invention
|
Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosing. Di... |
|
|
Invention
|
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins.
Disclosed... |
|
|
Invention
|
High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing.
Disclosed are metho... |
|
|
Invention
|
High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing. Disclosed are method... |
|
2022
|
Invention
|
Tolerogenic synthetic nanocarriers to reduce antibody responses.
Disclosed are synthetic nanocar... |
|
|
Invention
|
Multiple dosing with viral vectors. This invention relates, at least in part, to repeated lower d... |
|
|
Invention
|
Methods and compositions for attenuating anti-viral transfer vector igm responses.
Provided here... |
|
|
Invention
|
Viral vector dosing protocols. Disclosed, at least in part, are dosings of viral vectors concomit... |
|
|
Invention
|
Methods and compositions for attenuating anti-viral transfer vector igm responses. Provided herei... |
|
|
Invention
|
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nan... |
|
|
Invention
|
Osmotic mediated release synthetic nanocarriers.
This invention relates, at least in part, to os... |
|
|
Invention
|
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppres... |
|
2021
|
Invention
|
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance ... |
|
|
Invention
|
Compositions for reducing immune responses against immunoglobulin proteases. Disclosed are method... |
|
|
Invention
|
Methods and compositions for reducing immune responses against immunoglobulin proteases.
Disclos... |
|
|
Invention
|
Methods and compositions related to synthetic nanocarriers.
This invention relates to synthetic ... |
|
|
Invention
|
Methods and compositions related to synthetic nanocarriers. This invention relates to synthetic n... |
|
|
Invention
|
Methods and compositions using synthetic nanocarriers comprising immunosuppressant.
Provided her... |
|
|
Invention
|
Methods and compositions using synthetic nanocarriers comprising immunosuppressant. Provided here... |
|
2020
|
Invention
|
Formulations and doses of pegylated uricase.
Provided herein are methods and compositions relate... |
|
|
Invention
|
Formulations and doses of pegylated uricase. Provided herein are methods and compositions related... |
|
|
Invention
|
Methods and compositions for treating liver diseases and disorders.
Provided herein are methods ... |
|
|
Invention
|
Methods and compositions for inducing autophagy.
Provided herein are methods and compositions re... |
|
|
Invention
|
Methods and compositions for inducing autophagy. Provided herein are methods and compositions rel... |
|
2018
|
G/S
|
vaccines; pharmaceutical preparations used for the treatment and prevention of immunological dise... |
|
2011
|
G/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
|
|
G/S
|
Vaccines; pharmaceutical preparations used for the treatment and prevention of immunological dise... |
